SQZ Biotechnologies Net Income 2020-2023 | SQZ
SQZ Biotechnologies net income from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SQZ Biotechnologies Annual Net Income
(Millions of US $) |
| 2022 |
$-79 |
| 2021 |
$-69 |
| 2020 |
$-51 |
| 2019 |
$-32 |
SQZ Biotechnologies Quarterly Net Income
(Millions of US $) |
| 2023-03-31 |
$-18 |
| 2022-12-31 |
$-14 |
| 2022-09-30 |
$-23 |
| 2022-06-30 |
$-22 |
| 2022-03-31 |
$-21 |
| 2021-12-31 |
$-12 |
| 2021-09-30 |
$-22 |
| 2021-06-30 |
$-19 |
| 2021-03-31 |
$-15 |
| 2020-12-31 |
$-18 |
| 2020-09-30 |
$-12 |
| 2020-06-30 |
$-10 |
| 2020-03-31 |
$-11 |
| 2019-12-31 |
|
| 2019-09-30 |
$-8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
